Collagenesis

Collagenesis was a regenerative medicine company specializing in the development and manufacture of collagen-based scaffolds for wound care and surgical repair. The company utilized a proprietary processing technology to create biocompatible matrices that facilitate tissue regeneration and structural support. Its portfolio included products like FortaDerm and NuShield, which were used to treat complex chronic wounds and reinforce soft tissue during surgery. The company's technology platform focused on preserving the natural structure of collagen to optimize healing outcomes. In 2010, Collagenesis was acquired by Organogenesis, a leader in the regenerative medicine space, to enhance its product offerings and manufacturing scale. This acquisition allowed Organogenesis to integrate Collagenesis's unique collagen-processing capabilities into its broader commercial infrastructure.